Policy / Regulatory

NMPA’s 2022 Drug Supervision Report: Clinical Trials and Market Filings on the Rise

CompanyMedical Device

Alcon Laboratories’ Innovative Intraocular Lens Approved by China’s NMPA

CompanyDrug

Biosyngen Receives US FDA IND Approval for T-Cell Redirection Therapy for EBV-Positive Lymphoma

CompanyDeals

EOC Pharma Group Partners with China National Accord Medicines for Distribution Rights

CompanyDeals

Ubrigene Secures RMB 150 Million in Series C+ Financing to Expand Global CGT CDMO Platform

CompanyDeals

Shanghai Huikai Medical Technology Secures Series A+ Funding for Prostate Stent System

CompanyDrug

Shandong Jincheng Pharmaceutical Initiates Phase II Study for LT-01 Antibacterial Drug

CompanyDeals

RemeGen Ltd Partners with Shandong Cancer Hospital for ADC Development and Integrated System

CompanyDeals

Nona Biosciences Partners with Dr. Michael S. Diamond for Viral Disease Monoclonal Antibody Research

CompanyDeals

Everest Medicines and SPH Keyuan Ink MoU to Expand Xerava Distribution in China

CompanyDrug

Innovent Biologics Presents IBI351 Phase I Results at AACR Annual Meeting

Medical DevicePolicy / Regulatory

National Center Reports Increase in Medical Device Adverse Event Reports for 2022